Event logo
Sciforum
Program Overview
Program Overview

Click here to register for ECB 2025 for free! The registration includes attendance at all conference sessions.

12 May 2025
9:00–11:30 CEST		 13 May 2025
9:00–12:00 CEST		 14 May 2025
9:00–11:30 CEST		 15 May 2025
9:00–10:00 CEST
Session 2. Immunotherapy and Adverse Effects

Session 7. Gene Therapy and Gene Editing		 Session 5. Biomedicine in Cardiovascular Diseases Session 9. Molecular Mechanisms of Neurodegeneration Flash Poster Session
12 May 2025
13:00–15:30 CEST		 13 May 2025
13:00–15:30 CEST		 14 May 2025
13:00–16:00 CEST
Session 4. Immune System, Tumor Immunology and Autoimmune Disease Session 3. Tumor Microenvironment Session 1. Insulin Resistance or Hyperinsulinemia

Session 6. Diabetes, Obesity and Metabolic Diseases

Session 8. Rare Diseases

ECB 2025 Program (DAY1)
Session 2. Immunotherapy and Adverse Effects
Session 7. Gene Therapy and Gene Editing
Date: 12 May 2025 (Monday)
Time: 9:00 CEST, Basel | 03:00 EDT, New York | 15:00 CST Asia, Beijing
Time in CEST Speaker Title
9:00–9:10 Prof. Allan Stensballe
Event Chair
 Welcome from the Event Chair
9:10–9:15 Prof. Allan Stensballe
Session Chair

Welcome from the Session Chair
S2. Immunotherapy and Adverse Effects
9:15–9:30 Giulia Calafato Comparative Analysis of Immunotoxins Efficacy on 2D and 3D Models of Sarcoma
9:30–9:45 Simon LLEDO Combined in Vivo and in Cellulo Approach to Study the Role of Endothelial Cells and the NLRP3 Inflammasome in Cardiac Dysfunction Associated with Immune-Mediated Myocarditis
9:45–10:00 Firoaguer Isaure Transcriptional Impact of Pro-Inflammatory Cytokines in hiPSC-Derived Endothelial Cells and Cardiomyocytes: Insights into ICI-induced Myocarditis
10:00–10:15 Francesco Biscotti A New Edible Plant-Derived Toxin as Potential Candidate for Immunotherapy: Evaluation of Cytotoxic Profile on Intestinal Cells
10:15–10:30 Anderas Carus Autoantibody Driven Prediction of Immunotoxicity from PD-1 Treatment in NSCLC Patients—a Precision Proteomics Approach
10:30–10:40 Dr. Songwei Tan
Session Chair		 Welcome from the Session Chair
S7. Gene Therapy and Gene Editing
10:40–11:05

Prof. Dr. Huang Deng
Invited Speaker

 Reshaping Tumor Microenvironment Through Polymeric Nanoparticles Featured with CRISPRi System and Epigenetic Inhibitor
11:05–11:20 Claudia Florentina Stroe Genetic Mutations and Pathways Underlying the Correlation Between Colorectal and Gastric Cancer
Session 4. Immune System, Tumor Immunology and Autoimmune Disease
Date: 12 May 2025 (Monday)
Time: 13:00 CEST, Basel | 07:00 EDT, New York | 19:00 CST Asia, Beijing
Time in CEST Speaker Title
13:00–13:10

Dr. Giuseppe Cappellano
Dr. Maria-Ioanna (Marianna) Christodoulou
Session Chairs

 Welcome from the Session Chairs
S4. Immune System, Tumor Immunology and Autoimmune Disease
13:10–13:35

Dr. Davide Raineri
Invited Speaker

 From Data to Diagnosis: Biomarker Discovery in Amyotrophic Lateral Sclerosis
13:35–14:00

Prof. Dr. Patrícia C. Pires
Invited Speaker

 Recent Advances in Nanomedicine for Skin Cancer Immunotherapy—a Focus on Nanosystems, Drug Repurposing and co-Loading for Synergistic Effects
14:00–14:15 Francesca Vella The Prevalence of Anti-Nuclear Autoantibodies in a Population Exposed to Natural Asbestiform Fibers: a Cross-Sectional Study
14:15–14:30 Garnet Eister Shared Genetic Risk and Pathways Between Asthma and Celiac Disease
14:30–14:45 Hicham Wahnou Anti-Arthritic Potential of Artemisia herba-alba in Carrageenan and Complete Freund's Adjuvant-Induced Arthritis Models in Rats
14:45–15:00 Olga Pershina Pulmonary Fibrosis and Lung Cancer: Unity and Difference of Cellular Processes
15:00–15:15 Franklin Chamorro Natural Extracts and Autoimmunity: The Therapeutic Potential of Kiwi Polyphenols
15:15–15:30 Allan Stensballe Novel Biomarkers for Diagnosing Prosthetic Joint Infection and Chronic Joint Pain Following Total Knee and Hip Arthroplasty - An Exploratory Study
15:30–15:45 Mona Sami Awad The specific combinations of cytokines and tumor-derived factors determine particular immunosuppressive properties of in vitro generated murine myeloid-derived suppressor cells
ECB 2025 Program (DAY2)
Session 5. Biomedicine in Cardiovascular Diseases
Date: 13 May 2025 (Tuesday)
Time: 09:00 CEST, Basel | 03:00 EDT, New York | 03:00 CST Asia, Beijing
Time in CEST Speaker Title
9:00–9:10 Prof. Dr. Serafino Fazio
Event Chair		 Welcome from the host (Event Chair)
S5. Biomedicine in Cardiovascular Diseases
9:10–9:35 Prof. Dr. Ada Popolo
Invited Speaker		 The Productive Effect of Simvastatin on Doxorubicin-Induced Short-Term Cardiotoxicity
9:35–9:50 Yongting Luo The Activator Protein-1 Complex Governs a Vascular Degenerative Transcriptional Programme in Smooth Muscle Cells to Trigger Aortic Dissection and Rupture
9:50–10:05 Alisa Pautova Sepsis-Associated Aromatic Metabolites: Universal Markers of Bacterial Inflammation and Mortality in High-Risk Patients
10:05–10:20 Sepideh Jafari Natural Inhibitors of the β2-Adrenergic Receptor: A Computational Study for Targeting GPCR-Mediated Diseases
10:20–10:35 Haiyan Wu The Protective Role of the SGLT2 Inhibitor Empagliflozin in an Endothelial Inflammation Model
10:35–10:50 Riwka Palant Hormone-Independent Sex Differences in Pro-Inflammatory and Adhesion Mediators in a Cellular Model of Atherosclerosis
10:50–11:05 Ahmed Farag Exploring the Role of Anatomical Origin in the Cardiomyocyte Differentiation of Adipose-Derived Stem Cells: Metabolomic Profiling and Pathway Analysis
11:05–11:20 Asmaa Elhaieg Comparative Outcomes of Local and Systemic Mesenchymal Stem Cell Therapies on Periodontal Regeneration and Cardiac Health in a Rat Model of Periodontitis
Session 3. Tumor Microenvironment
Date: 13 May 2025 (Tuesday)
Time: 13:00 CEST, Basel | 07:00 EDT, New York | 19:00 CST Asia, Beijing
Time in CEST Speaker Title
13:00–13:10

Prof. Dr. Georgia Levidou
Session Chair

 Welcome from the Session Chair
S3. Tumor Microenvironment
13:10–13:40

Prof. Dr. Michele Ammendola
Keynote Speaker

 The Tumor Microenvironment in Gastrointestinal Cancers Surgically Treated
13:40–13:55 Karolina Beton-Mysur Can Statins Transform Human Colon Cell Behavior? Unveiling the Insights from Raman Imaging and AFM.
13:55–14:10 Aditya Vayalapalli DAVID Analysis Suggests Novel Chemoresistance Pathways in Ovarian Cancer
14:10–14:25 Domenico Damiani Translational Clinical Feasibility of Recent Advances in Liquid Biopsy Technology in Effusion Fluids: Preliminary Results
14:25–14:40 EMİNE AKPINAR Quantum Artificial Intelligence in Tumor Classification: An Innovative Method for Biomedical Data Analysis
14:40–14:55 Irina Valerievna Pronina Alterations in the Expression of a Group of Genes Associated with the Epithelial-Mesenchymal Transition in Lung Cancer: a Pilot Study
ECB 2025 Program (DAY3)
Session 9. Molecular Mechanisms of Neurodegeneration
Date: 14 May 2025 (Wednesday)
Time: 9:00 CEST, Basel | 03:00 EDT, New York | 03:00 CST Asia, Beijing
Time in CEST Speaker Title
9:00–9:10 Prof. Masaru Tanaka
Session Chair

Welcome from the Session Chair
S9. Molecular Mechanisms of Neurodegeneration
9:10–9:35 Dr. Mario García Domínguez
Invited Speaker		 A Comprehensive Analysis of Fibromyalgia and the Role of the Endogenous Opioid System
9:35–9:50 ISHANT DIWAKAR DAHAKE Nanomechanics and Conformational Polymorphism in Neurotoxic Proteins: Understanding Amyloidogenic Neurodegenerative Diseases
9:50–10:05 Nivedita Adhikari Development and Assessment of a Candesartan-loaded Bilosomal In Situ gel for Targeted Nose-to-Brain Delivery
10:05–10:20 Elika Valehi Advancement in Liposomal Technology with Various Active Compounds for Neurodegenerative Disease Treatment
10:20–10:35 David Joshua Ferguson Design of Partial Agonists of ADAMTS Metalloproteinases as Therapeutics for Neurodegenerative Diseases
10:35–10:50 Hugo F. Costa-Almeida Discovery of Potent Positive Allosteric Modulators of the D2 Receptors through Conjugation of Melanostatin Neuropeptide with Amantadine
10:50–11:05 Ezgi Nur YUKSEK Neuroprotective Effects of the Flowers of Camellia Japonica Var. Hagoromo: A Potential Candidate for Neurodegenerative Disease Treatment
11:05–11:20 Beatriz L. Pires-Lima Discovery of Potent Melanostatin-Based Positive Allosteric Modulators of the Dopamine D2 Receptors Using Heteroaromatic Scaffolds
11:20–11:35 Roxana Gheorghita The impact of persistent neurological manifestations in Long COVID-19 syndrome on daily life quality
S1. Insulin Resistance or Hyperinsulinemia
S6. Diabetes, Obesity and Metabolic Diseases
Date: 14 May 2025 (Wednesday)
Time: 13:00 CEST, Basel | 07:00 EDT, New York | 19:00 CST Asia, Beijing
Time in CEST Speaker Title
13:00–13:10 Prof. Dr. Serafino Fazio
Session Chair

Welcome from the Session Chair
S1. Insulin Resistance or Hyperinsulinemia
S6. Diabetes, Obesity and Metabolic Diseases
13:10–13:35 Dr. Hui Hannah Xiaoyan
Invited Speaker		 Non-canonical energy expenditure in adipocytes: mechanisms and intervention strategies
13:35–13:50

Ana Sofia Vallés

 Maternal Metabolic Syndrome Impairs Offspring Neurodevelopment, Behavior and Metabolism with Sexual Dimorphism
13:50–14:05 DIWAKAR DAHAKE The Role of Insulin Resistance in Congestive Heart Failure, Impaired Glucose Tolerance, and Hypertension
14:05–14:20 Ana Pérez Vázquez A Systematic Review of the Potential Applications of Nutrigenomics to Prevent and Alleviate Metabolic Disorders
14:20–14:35 MAUL SHREE Bioinformatic Analysis of Retatrutide's Impact on Galectin-3 Signaling Networks in Type 2 Diabetes Mellitus: A Systems Biology Approach
S8. Rare Diseases
Date: 14 May 2025 (Wednesday)
Time: 14:35 CEST, Basel | 07:35 EDT, New York | 19:35 CST Asia, Beijing
14:35–14:45 Dr. Francisco J. del Castillo
Session Chair		 Welcome from the Session Chair
S8. Rare Diseases
14:45–15:15

Dr. Daniel de Vicente
Keynote Speaker

 The role of patient associations in increasing awareness for rare diseases and advocating for research
15:15–15:30 Lisa Elm Deciphering Molecular Alterations of the Hippo Signaling Pathway in Thymic Epithelial Tumors Using Immunohistochemistry
15:30–15:45 Gianluca Baldanzi The SAP – WASP – DGKα Axis in Rare Hematological Diseases
15:45–16:00 Manshi Rana Therapeutic potential of natural plant derivatives against retinoblastoma
ECB 2025 Program (DAY4)
Flash Poster Session
Date: 15 May 2025 (Thursday)
Time: 9:00 CEST, Basel | 03:00 EDT, New York | 03:00 CST Asia, Beijing
Time in CEST Speaker Title
9:00–9:10 Event Host Opening: Welcome from the Event Host
9:10–9:15 Marlene Santos Exploring the Role of Oral Antidiabetic Medications as Adjuncts in Depression Treatment
9:15–9:20 Yassine Mouniane Biomedical Approaches Involving the Carob Tree (Ceratonia siliqua L.) for the Management of Obesity and Diabetes
9:20–9:25 MAUL SHREE Bioinformatics Analysis of Retatrutide on Insulin Resistance Pathway Leading to T2DM
9:25–9:30 Ana Olívia Serra Jorge Withaferin A from Withania somnifera: A Plant-Based Immunomodulator to Reduce Adverse Effects of Cancer Immunotherapy
9:30–9:35 Kunpeng Wang Comprehensive Transcriptomic Profiling and ceRNA Network Analysis Reveal Hub Genes and Therapeutic Targets in HPV-Positive Head and Neck Squamous-Cell Carcinoma
9:35–9:40 Veronica Filetti Evaluation of ncRNA Expression Levels in the Lung after Environmental Exposure to Fluoro-Edenite Fibers
9:40–9:45 Parsa Mahmood Dar Exploring the Advances in Plaque Psoriasis Research: A Scientometric Analysis and Visualization (2000-2025)
9:45–9:50 Alexandru Vasile Rusu Stabilized Curcumin in Emulsions and Hydrogel Systems: A Nutritional Strategy for Cardiovascular and Renal Protection in Hypercholesterolemia
9:50–9:55 Mariam Moalla Genetic Diagnosis of 46,XY Disorders of Sex Development (DSDs): Insights for Personalized Management
9:55–10:00 Celeste Moya-Valera Comprehensive Analysis of Genetic and Environmental Factors Influencing Type 2 Diabetes in the Spanish Population with NGS and the SEQENS Algorithm
ECB2025
ecb@mdpi.com
Powered by Sciforum
Disclaimer
Terms and ConditionsPrivacy PolicyAccessibility